A significant decrease in the survival was evident in all the colon cancer patients having higher LDLR with higher LDHA or MCT-4 or FASN expression in comparison to higher LDLR with lower LDHA or MCT-4 or FASN expression (Supplementary Fig. 7.6—7.8). The gene discussed is FASN; the disease is malignant colon neoplasm.